New vistas in contraceptive technology

Gender and Development

Volumn 16, Issue 2, 2008, Pages 327-344

  Ramarao, Saumya ^a   Sitruk Ware, Regine ^a   Townsend, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46649093576     PISSN: 13552074     EISSN: 13649221     Source Type: Journal    
DOI: 10.1080/13552070802120525     Document Type: Article

References (53)

1. Adetunji, J. (2000) Condom use in marital and nonmarital relationships in Zimbabwe. International Family Planning Perspectives, 26:4, pp. 196-200.
2. Agadjanian, V. (2002) Men's talk about 'women's matters': Gender, communication, and contraception in urban Mozambique. Gender and Society, 16:2, pp. 194-215.
3. Aubeny, E. (2007) Are monthly menstrual periods optional? A European perspective. Reproductive Health Matters, 15:29, pp. 183-185.
4. Bawah, A. A. (2002) Spousal communication and family planning behavior in Navrongo: A longitudinal assessment. Studies in Family Planning, 33:2, pp. 185-194.
5. Becker, S. and Costenbader, E. (2001) Husbands' and wives' reports of contraceptive use. Studies in Family Planning, 32:2, pp. 111-129.
6. Beegle, K., Frankenberg, E. and Thomas, D. (2001) Bargaining power within couples and use of prenatal and delivery care in Indonesia. Studies in Family Planning, 32:2, pp. 130-146.
7. Benefo, K. D. (2004) Are partner and relationship characteristics associated with condom use in Zambian nonmarital relationships?. International Family Planning Perspectives, 30:3, pp. 118-127.
8. Biddlecom, A. E. and Fapohunda, B. M. (1998) Covert contraceptive use: prevalence, motivations, and consequences. Studies in Family Planning, 29:4, pp. 360-372.
9. Blanc, A. K. (2001) The effect of power in sexual relationships on sexual and reproductive health: An examination of the evidence. Studies in Family Planning, 32:3, pp. 189-213.
10. Brache, V., Croxatto, H., Sitruk-Ware, R., Maguire, R., Montero, J. C., Kumar, N., Salvatierra, A. M., Tejada, A. S., Cochon, L., Forcelledo, M. L., Lahteenmaki, P., Alvarez, F. and Faundes, A. (2007) Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: A potential candidate for "dual protection" emergency contraception. Contraception, 76:2, pp. 111-116.
11. Brenner, R. M., Coa, W., Mah, K., Tsong, Y., Sitruk-Ware, R. and Slayden, O. D. (2006) Zonal Differences in Hormonal Responsiveness during Decidualization in the Primate Endometrium.pp. 2-56.
12. Castle, S., Konate, M. K., Ulin, P. R. and Martin, S. (1999) A qualitative study of clandestine contraceptive use in urban Mali. Studies in Family Planning, 30:3, pp. 231-248.
13. Cheng, C. Y., Mo, M. Grima, J. et al. (2002) Indazole carboxylic acids in male contraception. Contraception, 65, pp. 265-268.
14. Cleland, J., Bernstein, S., Ezeh, A., Faundes, A., Glasier, A. and Innis, J. (2006) Family planning: The unfinished agenda. The Lancet, 368, pp. 1810-1827.
15. Eddy, E. M., Toshimori, K. and O'Brien, D. A. (2003) Fibrous sheath of mammalian spermatozoa. Microsc Res Tech, 61, pp. 103-115.
16. Family Health International (FHI) and the ACQUIRE Project/Engenderhealth (2006) Consultation on improving contraceptive continuation: Meeting proceedings.
17. Fraser, I. S., Weisberg, E., Kumar, N., Kumar, S., Humberstone, A. J., McCrossin, L., Shaw, D., Tsong, Y. Y. and Sitruk-Ware, R. (2007) An initial pharmacokinetic study with a Metered Dose Transdermal System(R) for delivery of the progestogen Nestorone(R) as a possible future contraceptive. Contraception, 76:6, pp. 432-438.
18. Glasier, A. F., Anakwe, R. Everington, D. et al. (2000) Would women trust their partners to use a male pill?. Human Reproduction, 15, pp. 646-649.
19. Glasier, A. F., Smith, K. B., van der Spuy, Z. M., Ho, P. C., Cheng, L., Dada, K., Welling, K. and Baird, D. T. (2003) 'Amenorrhea associated with contraception-an international study on acceptability. Contraception, 67:1, pp. 1-8.
20. Glasier, A. F., Gulmezoglu, A. M., Schmid, G. P., Moreno, C. G. and Van Look, P. F. A. (2006) Sexual and reproductive health: A matter of life and death. The Lancet, 368:4, pp. 1595-1607.
21. Greene, M. E. and Biddlecom, A. E. (2000) Absent and problematic men: demographic accounts of male reproductive roles. Population and Development Review, 26:1, pp. 81-115.
22. Handelsman, D. J. (2003) Editorial: Hormonal male contraception-lessons from the East when the Western market fails. Journal of Clinical Endocrinology and Metabolism, 88:2, pp. 559-561.
23. Hardon, A. (1994) The development of contraceptive technologies: A feminist critique. Focus on Gender, 2:2, pp. 40-44.
24. Hardon, A. (2006) Contesting contraceptive innovation: Reinventing the script. Social Science and Medicine, 62, pp. 614-627.
25. Heinemann, K., Saad, F., Wiesemes, M. and Heinemann, L. A. (2005) Expectations toward a novel male fertility control method and potential user types: Results of a multinational survey. Journal of Andrology, 26, pp. 155-162.
26. Interagency Gender Working Group (IGWG) and World Health Organization (WHO) (2005) A Summary of the "So What" Report: A Look at Whether Integrating a Gender Focus into Programmes Makes a Difference to Outcomes.
27. International Women's Health Coalition (IWHC) (1993) Women's Declaration on Population Policies: Women's Voices '94. Reproductive Health Matters, 1, p. 93.
28. Khan, M. E. and Townsend, J. W. (1999) Target-free approach: Emerging evidence. Implementing a Reproductive Health Agenda in India: The Beginning, Population Council, New Delhi
29. Kumar, N., Crozat, A., Li, F., Catterall, J. F., Bardin, C. W. and Sundaram, K. (1999) 7alpha-methyl-19-nortestosterone, a synthetic androgen with high potency: Structure-activity comparisons with other androgens. Journal of Steroid Biochemistry and Molecular Biology, 71:5, pp. 213-222.
30. Kumar, N., Koide, S. S., Tsong, Y. and Sundaram, K. (2000) Nestorone: A progestin with a unique pharmacological profile. Steroids, 65, pp. 629-636.
31. Lakha, F., Ho, P. C., Van der Spuy, Z. M., Dada, K., Elton, R., Glasier, A. F., Critchley, H. O., Williams, A. R. and Baird, D. T. (2007) A novel estrogen-free oral contraceptive pill for women: Multicentre, double-blind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel). Human Reproduction, 22:9, pp. 2428-2436.
32. Lande, R. and Richey, C. (2006) Expanding Services for Injectables.
33. Meriggiola, M. C., Cerpolini, S., Bremner, W. J., Mbizvo, M. T., Vogelsong, K. M., Martorana, G. and Pelusi, G. (2006) Acceptability of an injectable male contraceptive regimen of noresthisterone enanthate and testosterone undecanoate for men. Human Reproduction, 21:8, pp. 2033-2040.
34. Pleck, J. H., Sonenstein, F. L. and Ku, L. (1993) Changes in adolescent males' use of and attitudes toward condoms 1998-1991. Family Planning Perspectives, 25:3, pp. 106-110.
35. Population Council (1978)p. 138. Population Council, New York
36. Population Reference Bureau (2007) 2007 World Population Data Sheet.
37. RamaRao, S. and Mohanam, R. (2003) The quality of family planning programs: Concepts, measurements, interventions, and effects. Studies in Family Planning, 34:4, pp. 227-248.
38. Ringheim, K. (1996) Male involvement and contraceptive methods for men: present and future. Social Change, 26:3, pp. 89-99.
39. Ringheim, K. (2002) When the client is male: Client-provider interaction from a gender perspective. International Family Planning Perspectives, 28:3, pp. 170-175.
40. Sachs, A. (1994) Men, sex, and parenthood. World Watch, 7:2, pp. 12-19.
41. Scarabin, P. Y., Oger, E., Plu-Bureau, G. and the Estrogen and Thromboembolism Risk Study Group (2003) Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet, 362:9382, pp. 428-432.
42. Scott, A. and Glasier, A. (2006) Evidence based contraceptive choices. Best Practice and Research Clinical Obstetrics and Gynaecology, 20:5, pp. 665-680.
43. Sitruk-Ware, R. (2006) Contraception: An international perspective. Contraception, 73, pp. 215-222.
44. Sitruk-Ware, R., Small, M., Kumar, N., Tsong, Y. Y., Sundaram, K. and Jackanicz, T. (2003) Nestorone™: Clinical applications for contraception and HRT. Steroids, 68, pp. 907-913.
45. Sivin, I., Mishell Jr, D. R. Alvarez, F. et al. (2005) Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: A 1-year dose-finding trial. Contraception, 71, pp. 122-129.
46. Speizer, I. S., Whittle, L. and Carter, M. (2005) Gender relations and reproductive decision-making in Honduras. International Family Planning Perspectives, 31:3, pp. 131-139.
47. United Nations Population Division (2005)p. 37. United Nations Secretariat, Mexico City
48. United Nations Population Fund (1994)UNFPA, Cairo and New York
49. United Nations Population Fund (2004) The State of World Population 2004: The Cairo Consensus at Ten: Population, Reproductive Health and the Global Effort to End Poverty, UNFPA, New York
50. Varga, C. A. (2003) How gender roles influence sexual and reproductive health among South African adolescents. Studies in Family Planning, 34:3, pp. 160-172.
51. World Health Organization (2004) Medical Eligibility Criteria for Contraceptive Use, WHO, Geneva
52. World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), INFO Project (2007) Family Planning: A Global Handbook for Providers, CCP and WHO, Baltimore and Geneva
53. Zulu, E. (1998) The role of men and women in decision making about reproductive issues in Malawi.